Latest News
From the Journals
Low-dose rituximab cuts infection risk
A reduced dose of rituximab for RA maintenance saves money and reduces infection risk.
From the Journals
Ultrasound could have utility in predicting which RA patients stay in remission
The short-term predictive power of ultrasound-detected residual synovitis may be more significant than its long-term predictive power.
From the Journals
Recurrent serious infection risk captured in real world RA study
Organ class of the index infection has a large effect on future infections.
From the Journals
Arthritis treatment costs per person held steady from 2008 to 2014
But why did it cost $60 billion more in aggregate treatment costs in 2014?
Conference Coverage
Meta-analysis: Lifestyle changes improve psoriasis
GENEVA – Obese patients can reduce psoriasis severity and boost quality of life with diet or exercise.
Feature
CHIP out of cash amid government shutdown
Congress, President bicker while 9 million children lose insurance coverage.
Feature
HHS creates new religious freedoms division
The Trump administration has announced a new division within the U.S. Health & Human Services Department that aims to protect health care...
From the Journals
Predictors may help to spot risk for hydroxychloroquine nonadherence
A detailed look at the trajectories of patients who stop, continue, or never start the drug.
Conference Coverage
Ixekizumab beats ustekinumab for fingernail psoriasis, hands down
GENEVA – Clear nails in half of ixekizumab users by week 24.
From the Journals
Putting a number on biologic DMARD costs
Burden of rheumatoid arthritis “may become outsized” as more patients use biologic disease-modifying antirheumatic drugs.
From the Journals
Hydroxychloroquine use rising in SLE pregnancies
Initiation “remains low” in pregnant women with systemic lupus erythematosus.